“健康中国”背景下,我国正在逐步推进完善罕见病用药保障机制,这既是我国医疗保障高质量发展的内在需求,也是进一步深化医改的一项重点任务。本文通过梳理我国当前罕见病费用保障的政策与地方试行的改革现状,分析罕见病费用保障现实情况与人民群众就医需求的“三对”不平衡关系。最后结合国情提出医保做好“两项基础工作”、发挥“三个作用”的罕见病费用综合保障机制完善路径。
Abstract
Under the background of Healthy China, China is gradually promoting the improvement of drug guarantee mechanism for rare diseases, which is not only the inherent demand of high-quality medical insurance development in China, but also a key task of further deepening the reform of medical system. This paper analyzes the three pairs of unbalanced relationship between the reality of rare disease expense guarantee and the people's demand for medical treatment and insurance by analyzing the current policy of rare disease expense guarantee and the situation of local reform. Finally, based on the national conditions, this paper puts forward the direction of improving the comprehensive guarantee mechanism of rare disease expenses, which is to “do two basic work well” and “play three roles”.
关键词
罕见病 /
医改 /
综合保障 /
机制
Key words
rare diseases /
medical reform /
comprehensive security /
mechanism
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 康琦,杨浩,金春林.上海罕见病用药保障现状研究[J].世界临床药物,2022,43(02):130-134.DOI:10.13683/j.wph.2022.02.004.
[2] 黄如方,王超群,胡大洋,等.寻找罕见病用药保障更优策略.健康报〔N〕.2020-11-16(07).
[3] 张海琴,李顺平,冯俊超.商业健康保险在中国罕见病医疗保障中的应用现状、问题及对策[J].罕见病研究,2022,1(01):84-88.
[4] 河北日报.让罕见病不再“罕见”〔N〕.河北日报. 2019-02-28(12).
[5] 肖建华,王超群.罕见病防治和保障的支持体系:台湾的经验与启示[J].社会保障研究,2018(02):92-105.
[6] 何达,顾一纯,顾善清,等.我国商业医疗保险参与保障高值罕用药使用的现状[J].中国卫生资源,2021,24(06):631-635.DOI:10.13688/j.cnki.chr.2021.210485.
[7] 罗葛妹.惠民保将成商业险高质量起点国际金融报〔N〕.2022-06-20(07).
基金
福建省卫生健康委员会科技计划项目;项目名称:“福建省非中医类医院中医药发展政策研究”(2021zyg183)